Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 2500.00 | 1861.36 | 4079.17 | 3944.38 | 1.0335 | 1.0601 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 2500.00 | 1861.36 | 3989.00 | 3944.38 | 1.0127 | 1.0268 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 4187.17 | 3944.38 | 1.0607 | 1.1099 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 2500.00 | 1861.36 | 4143.83 | 3944.38 | 1.0510 | 1.0952 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 4044.33 | 3944.38 | 1.0249 | 1.0447 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 2500.00 | 1861.36 | 4010.00 | 3944.38 | 1.0172 | 1.0331 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 2500.00 | 1861.36 | 3303.00 | 3944.38 | 0.8378 | 0.6985 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 2500.00 | 1861.36 | 1967.00 | 3944.38 | 0.4988 | 0.0510 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 2500.00 | 1861.36 | 1921.00 | 3944.38 | 0.4877 | 0.0296 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 5000.00 | 3570.27 | 6076.33 | 6032.88 | 1.0073 | 1.0199 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 5000.00 | 3570.27 | 5952.00 | 6032.88 | 0.9872 | 0.9693 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 6237.67 | 6032.88 | 1.0338 | 1.0900 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 5000.00 | 3570.27 | 6079.50 | 6032.88 | 1.0079 | 1.0222 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 6037.33 | 6032.88 | 1.0000 | 0.9964 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 5000.00 | 3570.27 | 6054.17 | 6032.88 | 1.0036 | 1.0101 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 5000.00 | 3570.27 | 5436.83 | 6032.88 | 0.9018 | 0.7459 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 5000.00 | 3570.27 | 3570.00 | 6032.88 | 0.5925 | 0.0004 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 5000.00 | 3570.27 | 3069.00 | 6032.88 | 0.5094 | -0.1819 |
| Hs 578T | Erlotinib | 0.0033113 | uM | 10 | 156.25 | 66.59 | 311.33 | 314.92 | 0.9901 | 0.9917 |
| Hs 578T | Erlotinib | 0.01 | uM | 10 | 156.25 | 66.59 | 309.33 | 314.92 | 0.9952 | 0.9926 |
| Hs 578T | Erlotinib | 0.031623 | uM | 10 | 156.25 | 66.59 | 369.67 | 314.92 | 1.1981 | 1.1584 |
| Hs 578T | Erlotinib | 0.1 | uM | 10 | 156.25 | 66.59 | 315.00 | 314.92 | 0.9982 | 0.9918 |
| Hs 578T | Erlotinib | 0.31623 | uM | 10 | 156.25 | 66.59 | 372.00 | 314.92 | 1.1823 | 1.1460 |
| Hs 578T | Erlotinib | 1 | uM | 10 | 156.25 | 66.59 | 392.67 | 314.92 | 1.2509 | 1.2108 |
| Hs 578T | Erlotinib | 3.1623 | uM | 10 | 156.25 | 66.59 | 316.33 | 314.92 | 1.0203 | 1.0057 |